Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
CPI is looking to secure to the services of a consultant with knowledge of the biopharmaceutical industry to support current business opportunities arising from the Covid-19 pandemic. The appointed consultant is expected to engage with business development opportunities and represent CPI in third party consortium meetings. It is envisage this consultancy provision will be approximately 2 days per week up to 100 days in total. Please see the documentation pack at https://ne1procurementservices.com/ for more information.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| OB-Biotechnology Ltd | 11055320 | £189,330 | - |